Company profile: Impladent
1.1 - Company Overview
Company description
- Provider of regenerative bone graft products and resorbable membranes.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Impladent
Emerging Implant Technologies
HQ: Germany
Website
- Description: Provider of orthopedic medical implants, designing and manufacturing EIT cervical cages, EIT PLIF cages, and EIT TLIF cages. Founded in 2014 and headquartered in Tuttlingen, Germany; operates as a subsidiary of Johnson.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Emerging Implant Technologies company profile →
Degradable Solutions
HQ: Switzerland
Website
- Description: Provider of resorbable implants for the biomedical market and novel electrospinning capabilities, including a first-of-a-kind non-woven, synthetic, electrospun dental membrane with a CE mark.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Degradable Solutions company profile →
Catalyst OrthoScience
HQ: United States
Website
- Description: Provider of shoulder replacement systems and planning software, including the Archer CSR Total Shoulder System for accurate joint line restoration with bone and soft tissue preservation; the Archer R1 Reverse Shoulder System, a single-tray arthroplasty solution emphasizing bone preservation and surgeon-targeted implant positioning; and Archer 3D Targeting Software for individualized anatomic and reverse planning.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Catalyst OrthoScience company profile →
OrthogenRx
HQ: United States
Website
- Description: Provider of orthopedic medical devices for treating musculoskeletal conditions, offering hyaluronic acid knee osteoarthritis therapies GenVisc850 (5-injection) and TriVisc (3-injection), a Direct Purchase Program at reduced cost with prescriptions shipped to doctors, a Reimbursement Navigator online portal, and Medical Inquiries support. Operates via exclusive ex‑U.S. supply/license agreements and seeks U.S. generic approvals.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full OrthogenRx company profile →
Soteira
HQ: United States
Website
- Description: Provider of next-generation technologies for the treatment of vertebral compression fractures, with multiple products launched to advance patient care in osteoporotic bone repair.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Soteira company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Impladent
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Impladent
2.2 - Growth funds investing in similar companies to Impladent
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Impladent
4.2 - Public trading comparable groups for Impladent
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →